Among these, pancreatic lipase (PL; EC 3.1.1.3), which plays an essential role in the digestion of dietary lipids (about 50–70% of total dietary lipids)9, is a primary modulator of lipid metabolism and thus can be the most suitable target for the anti-obesity agent. Here, PNLIP is linked to obesity disorder.